The Role of Minimally Invasive Surgery in the Management of Inflammatory Bowel Disease: Current Trends and Future Directions
- PMID: 39219937
- PMCID: PMC11364265
- DOI: 10.7759/cureus.65868
The Role of Minimally Invasive Surgery in the Management of Inflammatory Bowel Disease: Current Trends and Future Directions
Abstract
Minimally invasive surgery (MIS) provides superior results in the surgical treatment of inflammatory bowel disease (IBD). There exist various minimally invasive procedures, each possessing its own set of benefits and drawbacks. This literature review outlines these methodologies and underscores their importance in enhancing the outcomes of patients with IBD. A grand total of 192 studies were carefully chosen and succinctly summarized. Conventional multiport laparoscopy is the most widely used MIS for IBD, with single-incision laparoscopy showing even better results. Robotic surgery offers comparable results but at higher costs and longer operation times. In the future, there will be widespread acceptance of single-incision laparoscopy and robotic surgery due to improved training and reduced expenses. Further research into the technology's utility in different IBD presentations could increase its usage.
Keywords: improving health outcomes; inflammatory bowel disease; minimally invasive surgery; public health care; robotic assited surgery.
Copyright © 2024, Rathod et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
References
-
- ACG clinical guideline: ulcerative colitis in adults. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. Am J Gastroenterol. 2019;114:384–413. - PubMed
-
- Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Heller F, Florian P, Bojarski C, et al. Gastroenterology. 2005;129:550–564. - PubMed
-
- A comprehensive review and update on ulcerative colitis. Gajendran M, Loganathan P, Jimenez G, et al. Dis Mon. 2019;65:100851. - PubMed
-
- A population-based case control study of potential risk factors for IBD. Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. Am J Gastroenterol. 2006;101:993–1002. - PubMed
Publication types
LinkOut - more resources
Full Text Sources